Pristine Pharma (India) Private Limited
About Pristine Pharma (India) Private Limited
Data last updated:
Pristine Pharma (India) Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 12 February 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2009PTC070721. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors Doraisami Rajesh (Whole-Time Director) and Vanmathy Venkatapathy.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Old No: 11/1C New No: 39/1C Vannier Street Choolaimedu, Chennai, Tamil Nadu, India – 600094.
As per the financials filed for FY 2021, the company reported a revenue of ₹35.89 Lakh, a decline of 44% compared to the previous year. For the same year it recorded a net loss of ₹44.41 Lakh (net margin -123.7%) and EBITDA of -₹41.34 Lakh (EBITDA margin -115.2%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 23% over five years.
As per MCA filings, the company has open charges of ₹1.15 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOld No: 11/1C New No: 39/1C Vannier Street Choolaimedu, Chennai, Tamil Nadu, India – 600094
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pristine Pharma (India) Private Limited
The main business activity of Pristine Pharma (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pristine Pharma (India) Private Limited FY 2021 filings available
Pristine Pharma (India) Private Limited reported revenue of ₹35.89 Lakh (down 44% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Pristine Pharma (India) Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 23% over five years, including a 44% fall in the latest year. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pristine Pharma (India) Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹35.89 Lakh | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹41.34 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹44.41 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pristine Pharma (India) Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -115.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -123.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pristine Pharma (India) are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pristine Pharma (India) Private Limited
Pristine Pharma (India) Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Optin Pharma Private Limited | ₹37.01 Lakh (FY 2025) | •••• | •••• | 770983.0% | •••• | Hyderabad, Telangana, India |
| Amneal Biopharma Solutions Private Limited | ₹36.5 Lakh (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Simova India Lifesciences Private Limited | ₹36.48 Lakh (FY 2019) | •••• | •••• | -46.0% | •••• | New Delhi, Delhi, India |
| Prasad Idea Labs Private Limited | ₹36.4 Lakh (FY 2025) | •••• | •••• | -81.0% | •••• | Hyderabad, Telangana, India |
| Anamle Design Solutions Private Limited | ₹36.33 Lakh (FY 2024) | •••• | •••• | 76.0% | •••• | Balasore, Odisha, India |
| Pristine Pharma (India) Private Limited this company | ₹35.89 Lakh (FY 2021) | •••• | •••• | -44.0% | •••• | Chennai, Tamil Nadu, India |
| Kronikare India Private Limited | ₹35.85 Lakh (FY 2023) | •••• | •••• | 19.0% | •••• | Bengaluru, Karnataka, India |
| Anubis Clinical Research Private Limited | ₹35.63 Lakh (FY 2023) | •••• | •••• | 225.0% | •••• | Chennai, Tamil Nadu, India |
| Diponed Research International Private Limited | ₹35.38 Lakh (FY 2024) | •••• | •••• | 3187.0% | •••• | Bangalore, Karnataka, India |
| Human Energy Research Center | ₹35.05 Lakh (FY 2024) | •••• | •••• | -48.0% | •••• | Kanpur, Uttar Pradesh, India |
| Dnadvent Lifesciences Private Limited | ₹33.76 Lakh (FY 2024) | •••• | •••• | 42.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Pristine Pharma (India) by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pristine Pharma (India) Private Limited
Pristine Pharma (India) Private Limited is audited by SUDHINDRAN & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SUDHINDRAN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pristine Pharma (India) Private Limited
Pristine Pharma (India) has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vanmathy Venkatapathy | Director | 05 Dec 2012 | 13 Years 10 Months | Current |
| Doraisami Rajesh | Whole-Time Director | 12 Feb 2009 | 17 Years 7 Months | Current |
Ownership and Shareholding of Pristine Pharma (India) Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pristine Pharma (India) Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2014 | Others | ₹75 Lakh | Open |
| 06 May 2013 | The Catholic Syrian Bank Ltd | ₹40 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Pristine Pharma (India) Private Limited
Employment history and EPFO contributions of people linked to Pristine Pharma (India).
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pristine Pharma (India) Private Limited
Pristine Pharma (India) Private Limited has 6 board changes on record since 2009: 2 appointments and 4 cessations. The latest: Vanmathy Venkatapathy ceased to be Additional Director on 10 Mar 2022.
Credit Ratings, Litigation & Regulatory Alerts for Pristine Pharma (India) Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pristine Pharma (India) Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pristine Pharma (India) Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pristine Pharma (India) Private Limited
Pristine Pharma (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pristine Pharma (India) Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pristine Pharma (India) Private Limited
Pristine Pharma (India) is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 12 February 2009 (17+ years old) and is registered under CIN U24100TN2009PTC070721.
Pristine Pharma (India) reported revenue of ₹35.89 Lakh for FY 2021 (down 44% YoY).
Pristine Pharma (India) has 2 current directors:
- Doraisami Rajesh - Whole-Time Director
- Vanmathy Venkatapathy - Director
Pristine Pharma (India) reported a net loss of ₹44.41 Lakh (net margin -123.7%) and EBITDA of -₹41.34 Lakh (EBITDA margin -115.2%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pristine Pharma (India) is -13% over three years and -23% over five years. In the latest year (FY 2021) revenue fell 44%. CAGR is the steady yearly rate that links the first and the last year.
No. Pristine Pharma (India) has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Pristine Pharma (India) is U24100TN2009PTC070721. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pristine Pharma (India) was incorporated on 12 February 2009, making it 17+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Pristine Pharma (India) by revenue are Optin Pharma Private Limited, Amneal Biopharma Solutions Private Limited, Simova India Lifesciences Private Limited, Prasad Idea Labs Private Limited, Anamle Design Solutions Private Limited and 5 more, all in the Pharma industry (Contract Research).
Vanmathy Venkatapathy ceased to be Additional Director on 10 Mar 2022. Poongavanam Andappan ceased to be Additional Director on 12 Jul 2021. Sriraam Venkateswara Thirukumarasubbiah ceased to be Whole-Time Director on 05 Dec 2012. Pristine Pharma (India) has 6 board changes on record in total.
The registered office of Pristine Pharma (India) is at Old No: 111C New No: 391C Vannier Street Choolaimedu, Chennai, Tamil Nadu, India – 600094.